H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.
The recommendations were made following a meeting that included experts from the FDA, the Centers for Disease Control and Prevention, and the Department of Defense.